Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”

المؤلفون المشاركون

Peng, Hanhui
Fang, Jun
Chen, Shuang
Jiang, Hongmei
Wu, Xiaosong

المصدر

Oxidative Medicine and Cellular Longevity

العدد

المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-2، 2ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2018-12-13

دولة النشر

مصر

عدد الصفحات

2

التخصصات الرئيسية

الأحياء

الملخص EN

In the article titled “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases” [1], there is a missing section that should be added between sections 4 and 5 as follows:

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Chen, Shuang& Jiang, Hongmei& Peng, Hanhui& Wu, Xiaosong& Fang, Jun. 2018. Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”. Oxidative Medicine and Cellular Longevity،Vol. 2018, no. 2018, pp.1-2.
https://search.emarefa.net/detail/BIM-1210942

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Chen, Shuang…[et al.]. Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”. Oxidative Medicine and Cellular Longevity No. 2018 (2018), pp.1-2.
https://search.emarefa.net/detail/BIM-1210942

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Chen, Shuang& Jiang, Hongmei& Peng, Hanhui& Wu, Xiaosong& Fang, Jun. Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”. Oxidative Medicine and Cellular Longevity. 2018. Vol. 2018, no. 2018, pp.1-2.
https://search.emarefa.net/detail/BIM-1210942

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1210942